Tag:
Carbaglu
Latest Headlines
Latest Headlines
FDA panel OKs Recordati's Carbaglu
An FDA panel has unanimously backed the approval of Carbaglu, Recordati's treatment for patients with a rare and fatal disease called NAGS deficiency. The vote of confidence comes despite earlier
FDA panel questions Recordati drug
There could be trouble ahead for Italian drug developer Recordati. FDA staff reviewers have some questions about Carbaglu, the company's treatment for patients with NAGS deficiency. NAGS, which is
